So great to work on this commentary with @heme_fan, published today in @BloodJournal! We comment on the recent findings by Ryu et al on the risk of venous thromboembolism with hereditary thrombophilias, including double heterozygous FVL/PTGM, and their prevalence.

Double-heterozygous FVL/PTGM: double the trouble | Blood | American Society of Hematology - excellent editorial. Great study on risks with common combinations of thrombophilia ⁦⁦@heme_fan⁩ 👏🏼

Congrats to senior/chief fellow Barbara Lam on this exciting work! Machine learning natural language processing for identifying venous thromboembolism: Systematic review and meta-analysis

🗨️📄 Revamp your consults with our new paper on communication! Learn how a novel framework could streamline your workflow. 🔗: https://t.co/P5mgTtgF3p ✍️:@josephinecool1

Making the diagnosis of APS is tricky. With the new 2023 ACR/EULAR APS classification, we share our approach on diagnosing and treating APS in pregnancy. https://t.co/qCklbEDZsz @UofUHematology

1/5 SVT - TO ANTICOAGULATE OR NOT TO ANTICOAGULATE I posted a poll asking whether and how you would anticoagulate a patient with superficial vein thrombosis (SVT) of the leg. There was a pretty even split in votes between the 4 options.

1/10 ORAL IRON IN IRON DEFICIENCY ANEMIA (IDA) I tweeted a poll asking how you would treat a case of uncomplicated IDA with oral iron. The options and responses are shown below:

Brillant talk by Dr. @LaraNRoberts1 Most common procedures done in patients with liver dysfunction are at low risk of bleeding Hemostatic markers are NOT useful! Vit K and transfusion of FFP to correct INR are NOT useful! #ASH23 👇

.@tariqkewan presents his #ASH23 Abstract Achievement 🌟Award winning🌟 poster "Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndromes #MDS Treated with Hypomethylating Agents" @YaleHematology @Dr_AmerZeidan @SmilowCancer

Another successful #ASH2023 @BIDMC_HOFellows

Dr. Alexander Pine @BenignHeme presents on "Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry" at #ASH23 @YaleHematology @SmilowCancer @YaleMed @YNHH

Past and present fellows getting the blood pumping to start the day #ASH2023

In recognition of his innovation, @GeorgeGoshuaMD has been named a Young Explorer Award finalist by NOMIS & @ScienceMagazine. Dr. Goshua shared how mathematical models can hold the key to equitable patient care in, "Napkin math can change the world." https://t.co/tn3caIs4k5

We combined genetic information with geospatial data in the Biobank and found that the geospatial distribution of these clusters replicated the colonization history in the Greater Boston Area (3/11)

Seeing <5k platelets in a patient. Hematologist vs everyone else🤣

Today on #worldthrombosisday #WTDay23 @thrombosisday important to recognize the devastating consequences of thromboembolism on people with cancer @isth @StopTheClot

A fascinating work is published today @Nature by Zhang & Zhang et al. on a serendipitous discovery of haemoglobin expression outside the RBC cells--in chondrocytes--and their critical role in keeping our cartilage alive under an oxygen-deprived environment.

For clinical trainees interested in getting started in data sciences / bioinformatics, would check out the resources compiled by & guidance from @RomitB_MD a couple years ago https://t.co/FUMP8kqh7v @ACCinTouch @MGHHeartHealth

Can genetics shed light on the causes of bradyarrhythmias🫀? We are excited to release a @medrxivpreprint describing findings from collaborative genomic🧬analyses of bradyarrhythmias across 10 different studies:

What can genetics tell us about cardiac conduction disease? 🫀 In our recent @medrxivpreprint preprint, we studied the role of common and rare genetic variants in bradyarrhythmia ( https://t.co/ly6gEbSwPj). @LuChenWeng @joeltramo